[HTML][HTML] Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis.

R Wade, E South, S Anwer, S Sharif-Hurst… - Health technology …, 2023 - ncbi.nlm.nih.gov
BACKGROUND A wide range of ablative and non-surgical therapies are available for
treating small hepatocellular carcinoma in patients with very early or early-stage disease …

The effectiveness of ablative and non‐surgical therapies for early hepatocellular carcinoma: Systematic review and network meta‐analysis of randomised controlled …

E South, R Wade, S Anwer, S Sharif‐Hurst… - Cancer …, 2023 - Wiley Online Library
Abstract Background & Aims Non‐surgical therapies are frequently used for patients with
early or very early hepatocellular carcinoma (HCC). The aim of this systematic review and …

Comparative efficacy and safety between ablative therapies or surgery for small hepatocellular carcinoma: a network meta-analysis

GQ Zhu, M Sun, WT Liao, WH Yu, SL Zhou… - Expert Review of …, 2018 - Taylor & Francis
Background: Major treatments for small hepatocellular carcinoma (SHCC) include
percutaneous ethanol injection (PEI), percutaneous acetic acid injection (PAI) …

Efficacy and safety of various primary treatment strategies for very early and early hepatocellular carcinoma: a network meta-analysis

S Yang, H Lin, J Song - Cancer Cell International, 2021 - Springer
Background Several treatments are available for treatment of early and very early-stage
Hepatocellular Carcinoma, also known as small Hepatocellular Carcinoma (SHCC) …

Comparison of 2 curative treatment options for very early hepatocellular carcinoma: Efficacy, recurrence pattern, and retreatment

TH Kim, JM Chang, SH Um, H Jee, YR Lee, HA Lee… - Medicine, 2019 - journals.lww.com
Curative treatments for very early-stage hepatocellular carcinoma (HCC), defined as single
HCC with a maximum diameter of< 2 cm in patients with well-preserved liver function …

[HTML][HTML] Emerging curative-intent minimally-invasive therapies for hepatocellular carcinoma

KE Zane, PB Nagib, S Jalil, K Mumtaz… - World journal of …, 2022 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the most common cause of liver malignancy and the
fourth leading cause of cancer deaths universally. Cure can be achieved for early stage …

[HTML][HTML] Clinical outcome of small hepatocellular carcinoma after different treatments: a meta-analysis

W Dong, T Zhang, ZG Wang, H Liu - World Journal of …, 2014 - ncbi.nlm.nih.gov
AIM: To compare clinical outcomes between surgical resection (RES) and nonsurgical-RES
(nRES) ablation therapies for small hepatocellular carcinoma (HCC). METHODS: MEDLINE …

[HTML][HTML] Treatment of solitary hepatocellular carcinoma up to 2 cm: A PRISMA-compliant systematic review and meta-analysis

H Fan, C Zhou, J Yan, W Meng, W Zhang - Medicine, 2020 - journals.lww.com
Background: In recent years, there has been considerable uncertainty about the optimal
treatment option for very early hepatocellular carcinoma (HCC) with tumor size less than 2 …

Comparison of the therapeutic outcomes between surgical resection and percutaneous ablation for small hepatocellular carcinoma

K Hasegawa, T Aoki, T Ishizawa, J Kaneko… - Annals of Surgical …, 2014 - Springer
There seems to be a consensus in regard to the initial treatment of small hepatocellular
carcinomas (HCCs): either percutaneous ablation or liver resection should be selected …

Current treatment for small (< 5 cm) hepatocellular carcinoma: evolving roles for ablation and resection

A Pugalenthi, CS Cutter, Y Fong - Advances in surgery, 2014 - advancessurgery.com
INTRODUCTION Liver cancer is the fifth most common cancer in men (523,000 cases, 7.9%
in total) and seventh most common cancer in women (226,000 cases, 6.5% in total). Eighty …